Form 4: Elanco Animal Health Executive Reports Stock Unit Transaction

Rajeev A. Modi, Executive Vice President at Elanco Animal Health, reported a transaction involving deferred stock units.

Summary

• Rajeev A. Modi, Executive Vice President of U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc., engaged in a transaction involving deferred stock units.
• The transaction, dated May 1, 2026, involved the acquisition of 65.6122 deferred stock units.
• Each deferred stock unit is equivalent to one share of Elanco Animal Health common stock or its cash equivalent.
• These units are set to settle in cash or shares upon termination of employment or in a specified future year, as per the Executive Deferral and Stock Match Plan.
• The reporting person's ownership of common stock following this transaction is 9,265.6213 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine executive stock transaction rather than a significant financial event or strategic shift.

Positives

• Executive engagement in equity plans can signal confidence in the company's future performance.
• The deferred stock units are part of a structured plan, indicating a formalized compensation and retention strategy.

Negatives

• The filing does not provide details on the specific value or cost basis of the deferred stock units at the time of acquisition, making it difficult to assess the immediate financial impact on the executive.
• The settlement of these units is contingent on future events (termination or specified year), introducing uncertainty regarding the timing of realization.

Risks

• The value of the deferred stock units is subject to fluctuations in Elanco Animal Health's stock price.
• The settlement of deferred stock units is dependent on the executive's continued employment or specific future conditions outlined in the plan.

Future Outlook

Deferred stock units are set to settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Industry Context

StockSavvy.ai notes that executive stock unit transactions are common in the animal health industry as a tool for compensation, retention, and aligning executive interests with shareholder value. This filing is a routine disclosure under SEC regulations.

Stakeholder Impact

• Shareholders: The transaction itself does not directly impact share price but is part of the broader executive compensation structure which influences long-term shareholder value.
• Employees: The existence of such executive compensation plans can influence morale and retention among other key personnel.
• Management: The transaction reflects the executive's participation in the company's equity incentive programs.

Next Steps

• Settlement of deferred stock units upon termination of employment or during a specified future year.
• Continued reporting of beneficial ownership changes as required by SEC regulations.

Key Dates

Keywords

Form 4, SEC Filing, Elanco Animal Health, Rajeev A. Modi, Deferred Stock Units, Executive Compensation, Insider Trading, Stock Ownership, ELAN